Flushing away the poo taboo, together!
What is it that stops us from talking about our digestive health, or poo, as openly as we’d talk about having a cold, a headache or back pain? After all, our poo is an indication...
7th March 2024
20th February 2019
Two ongoing research studies are actively recruiting participants. If you are a patient with IBS with Diarrhoea (IBS-D), or suffer from ulcerative colitis, you have the chance to shape future clinical research and healthcare in the UK.
Study 1: the TRITON study
This study is investigating treatment into IBS-D and needs patients to take part in a trial lasting up to 4 months.
You would need to take a study medication, record your symptoms, visit your local hospital 6 times, and have optional tests looking into bowel sensitivity and contractions.
There are various hospitals taking part in this research and travel expenses will be reimbursed.
Contact r.lalani@qmul.ac.uk or david.gunn@nottingham.ac.uk for more.
Study 2: IBD surveillance
This study seeks to improve our understanding of IBD surveillance for patients with ulcerative colitis. If you suffer from this condition and undergo dye spray colonoscopy every few years, the researchers are looking for your valuable input.
You will share your experiences as a patient, which could shape the way this service is delivered in the future. Location is not important as you may opt for online, virtual sessions. Otherwise, travel expenses will be reimbursed.
To find out more, email keithsiau@nhs.net.
What is it that stops us from talking about our digestive health, or poo, as openly as we’d talk about having a cold, a headache or back pain? After all, our poo is an indication...
7th March 2024
We’re delighted to take our free ‘Science of Digestion’ event to Hull next month (Tuesday 14th May 2024!) This is your opportunity to learn all about the hidden world inside your guts and the latest...
22nd April 2024
Download printable version (337.3KB pdf) OVERVIEW You might have noticed supply issues with pancreatic enzyme replacement therapy (PERT), sometimes also called pancreatin. This situation has progressed. It has now caused some people who need PERT...
16th April 2024
By submitting this form, you are consenting to Guts UK contacting you by email as detailed above. To make any changes to your preferences you can email us on info@gutscharity.org.uk or by calling us on 020 7486 0341. Your details are safe with us. Please read our Privacy Policy for more details.